Patterns of pncA mutations in drug-resistant Mycobacterium tuberculosis isolated from patients in South Korea

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 1, 2012, Pages 98-103

  Kim, H J ^a   Kwak, H K ^b   Lee, J ^a   Yun, Y J ^c   Lee, J S ^b   Lee, M S ^b   Min, S Y ^b   Park, S K ^d   Kang, H S ^d   Maeng, Y H ^a   Kim, S Y ^a   Kook, Y H ^c   Kim, Y R ^a   Lee, Keun Hwa ^a  

^a Jeju National University School of Medicine   (South Korea)

^b International Tuberculosis Research Center   (South Korea)

^c Seoul National University   (South Korea)

^d National Masan TB Hospital   (South Korea)

Author keywords

Amidohydrolases; Anti tuberculosis agents; Multidrug resistance; Mutation; pncA; South Korea; Tuberculosis

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; BACTERIAL DNA; CIPROFLOXACIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; OFLOXACIN; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; THIOACETAZONE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CONTROLLED STUDY; DNA SEQUENCE; FRAMESHIFT MUTATION; GENE DELETION; GENE MUTATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PNCA GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SOUTH KOREA; WILD TYPE;

ADULT; AMIDOHYDROLASES; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; GENOTYPE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PYRAZINAMIDE; REPUBLIC OF KOREA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84555220645     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.10.0739     Document Type: Article

References (17)

1. World Health Organization. Tuberculosis. Fact sheet no 104. Geneva, Switzerland: WHO, 2010. http://www.who.int/media centre/factsheets/fs104/en/ index.html Accessed September 2011.
2. World Health Organization. Global tuberculosis control - surveillance, planning, financing. WHO/HTM/TB 2008.393. Geneva, Switzerland: WHO, 2008.
3. Scorpio A, Zhang Y. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antitubercular drug pyrazinamide in tubercle bacillus. Nat Med 1996; 2: 662-667. (Pubitemid 26191953)
4. Miyagi C, Yamane N, Yogesh B, Ano H, Takashima T. Genetic and phenotypic characterization of pyrazinamide-resistant Mycobacterium tuberculosis complex isolates in Japan. Diagn Microbiol Infect Dis 2004; 48: 111-116. (Pubitemid 38221506)
5. Mphahlele M, Syre H, Valvatne H, et al. Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates. J Clin Microbiol 2008; 46: 3459-3464.
6. Hirano K, Takahashi M, Kazumi Y, Fukasawa Y, Abe C. Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis. Tubercle Lung Dis 1998; 78: 117-122.
7. Somoskovi A, Dormandy J, Parsons L M, et al. Sequencing of the pncA gene in members of the Mycobacterium tuberculosis complex has important diagnostic applications: identification of a species-specific pncA mutation in Mycobacterium canetti and the reliable and rapid predictor of pyrazinamide resistance. J Clin Microbiol 2007; 45: 595-599. (Pubitemid 46277031)
8. Juréen P, Werngren J, Toro J C, Hoffner S. Pyrazinamide resistance and pncA gene mutations in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2008; 52: 1852-1854. (Pubitemid 351614686)
9. Wayne L G. Simple pyrazinamidase and urease tests for routine identification of mycobacteria. Am Rev Respir Dis 1974; 109: 147-151.
10. World Health Organization. WHO report on the tuberculosis epidemic. Stop TB at the source. WHO/TB/95.183. Geneva, Switzerland: WHO, 1995.
11. Cheng S J, Thibert L, Sanchez T, Heifets L, Zhang Y. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada. Antimicrob Agents Chemother 2000; 44: 528-532. (Pubitemid 30117936)
12. Chan R C, Hui M, Chan E W, et al. Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. Antimicrob Agents Chemother 2007; 59: 866-873. (Pubitemid 47078721)
13. Park S K, Lee J Y, Chang C L, et al. pncA mutations in clinical Mycobacterium tuberculosis isolates from Korea. BMC Infect Dis 2001; 1: 4.
14. Lee K W, Lee J M, Jung K S. Characterization of pncA mutation of pyrazinamide-resistant Mycobacterium tuberculosis in Korea. J Korean Med Sci 2001; 16: 537-543. (Pubitemid 33741658)
15. Sreevatsan S, Pan X, Zhang Y, Kreiswirth B N, Musser J M. Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms. Antimicrob Agents Chemother 1997; 41: 636-640. (Pubitemid 27098417)
16. Ando H, Mitarai S, Kondo Y, et al. Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Japan. Clin Microbiol Infect 2010; 16: 1164-1168.
17. Doustdar F, Khosravi A D, Farnia P. Mycobacterium tuberculosis genotypic diversity in pyrazinamide-resistant isolates of Iran. Microb Drug Resist 2009; 15: 251-256.